Literature DB >> 30800271

Association of Breast Arterial Calcification Presence and Gradation with the Ankle-Brachial Index among Postmenopausal Women.

Carlos Iribarren1, Gabriela Sanchez1, Meng Lu1, Fatemeh Azamian Bidgoli2, Hyo-Min Cho2, Huanjun Ding2, Sabee Molloi2.   

Abstract

OBJECTIVE: To examine the association of breast arterial calcification (BAC) with the ankle brachial index (ABI), a sensitive metric of peripheral arterial disease (PAD), among postmenopausal women. Background: BAC is an emerging risk marker of cardiovascular disease (CVD).
METHODS: MINERVA (MultIethNic study of brEast aRterial calcium gradation and cardioVAscular disease) is a cohort of women aged 60 to 79 at baseline (10/24/2012 - 2/13/2015) who were free of symptomatic CVD at baseline. The analytical sample comprised 3,800 women with available ABI, BAC assessment and covariates. We performed cross-sectional logistic regression analysis.
RESULTS: 203 women (5.3%) had an ABI < 0.90 indicative of PAD, 26 (0.7%) had an ABI > 1.3 and 94% (n=3,571) had an ABI within normal limits. After adjustment for age, race/ethnicity, body mass index, smoking status, diabetes, hypertension, LDL-C, HDL-C, hs-CRP, estimated-GFR, urinary albumin/creatinine ratio, serum calcium, serum vitamin D and serum PTH, BAC presence remained significantly associated with ABI < 0.90 (OR=1.37; 95% CI, 1.01-1.87; p=0.04). After further adjustment for menopausal hormone therapy, parity and history of breast feeding, the association became marginally significant (OR=1.36; 95% CI, 0.99-1.85; p=0.05). No clear pattern of association was observed for increased gradation of BAC and ABI<0.9, and no significant associations were noted between BAC presence vs. absence or BAC gradation with ABI > 1.3.
CONCLUSIONS: Among asymptomatic postmenopausal women, presence of BAC was associated with PAD independently of traditional risk factors. Additional prospective studies are required to establish the value of BAC for prediction of incident PAD in the general population.

Entities:  

Keywords:  Breast arterial calcification; ankle brachial index; cohort study; peripheral artery disease; women’s health

Year:  2018        PMID: 30800271      PMCID: PMC6385879     

Source DB:  PubMed          Journal:  Eur J Cardiovasc Med        ISSN: 2042-4884


  43 in total

1.  Breast calcifications due to Mönckeberg medial calcific sclerosis.

Authors:  H Kim; J S Greenberg; M C Javitt
Journal:  Radiographics       Date:  1999 Sep-Oct       Impact factor: 5.333

2.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

3.  Arterial calcifications seen on mammograms: cardiovascular risk factors, pregnancy, and lactation.

Authors:  Angela H E M Maas; Yvonne T van der Schouw; David Beijerinck; Jan J M Deurenberg; Willem P T M Mali; Yolanda van der Graaf
Journal:  Radiology       Date:  2006-05-23       Impact factor: 11.105

Review 4.  Epidemiology and pathophysiology of lower extremity peripheral arterial disease.

Authors:  Lawrence A Garcia
Journal:  J Endovasc Ther       Date:  2006-02       Impact factor: 3.487

5.  Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.

Authors:  C M Shanahan; N R Cary; J R Salisbury; D Proudfoot; P L Weissberg; M E Edmonds
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

6.  Lack of association between breast artery calcification seen on mammography and coronary artery disease on angiography.

Authors:  Y Henkin; A Abu-Ful; I Shai; P Crystal
Journal:  J Med Screen       Date:  2003       Impact factor: 2.136

Review 7.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

8.  Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure.

Authors:  Carlos Iribarren; Alan S Go; Irina Tolstykh; Stephen Sidney; S Claiborne Johnston; David B Spring
Journal:  J Womens Health (Larchmt)       Date:  2004-05       Impact factor: 2.681

9.  Association of breast arterial calcifications detected by mammography and coronary artery calcifications quantified by multislice CT in a population of post-menopausal women.

Authors:  Annarita Pecchi; Rosario Rossi; Francesca Coppi; Guido Ligabue; Maria Grazia Modena; Renato Romagnoli
Journal:  Radiol Med       Date:  2003-10       Impact factor: 3.469

10.  How predictive is breast arterial calcification of cardiovascular disease and risk factors when found at screening mammography?

Authors:  Masako Kataoka; Ruth Warren; Robert Luben; Joanna Camus; Erika Denton; Elvis Sala; Nicholas Day; Kay-Tee Khaw
Journal:  AJR Am J Roentgenol       Date:  2006-07       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.